Butrans® (buprenorphine) Transdermal System CIII | Transdermal System Serious, life-threatening, or fatal respiratory depression may occur with use of BUTRANS, especially during initiation or following a dosage increase To reduce the risk of respiratory depression, proper dosing and titration of BUTRANS are essential
BUTRANS label - Food and Drug Administration Prolonged use of BUTRANS during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated
DailyMed - BUTRANS- buprenorphine patch, extended release BUTRANS is a transdermal system providing systemic delivery of buprenorphine, a mu opioid partial agonist analgesic, continuously for 7 days The chemical name of buprenorphine is
Buprenorphine for Chronic Pain - Veterans Affairs Consider an alternative initiation approach for patients unable to taper to 30 mg MEDD or with concern for history of intolerable opioid withdrawal during buprenorphine initiation
Butrans Patch: Uses, Dosage Side Effects - Drugs. com Butrans (buprenorphine) is a prescription transdermal skin patch used to treat severe and persistent pain that requires an opioid pain reliever, and that cannot be adequately treated with other options, including immediate-release opioid medications
label - Lexicomp Online Taking BUTRANS with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death